Search - tctmd.com

Displaying 101 - 120 of 175

Sort: Relevancy | Date

News Daily News

OMT Boosts Survival in Revascularized Patients at 10 Years

Michael O'Riordan

June 29, 2021

News Daily News

Less Cancer Among HF Patients Taking Statins, Registry Shows

Michael O'Riordan

June 23, 2021

News Daily News

Sleep Apnea Awareness, Treatment May Improve Some CVD Outcomes: AHA

L.A. McKeown

June 23, 2021

News Daily News

Statins Not Linked to Dementia or Memory Changes: ASPREE

Michael O'Riordan

June 21, 2021

News Daily News

Stopping Statins Ups CVD and Mortality Risks in Pill-Burdened Seniors

Michael O'Riordan

June 16, 2021

News Daily News

First PCIs Preceded by Many Modifiable Risk Factors: Registry Data

L.A. McKeown

June 16, 2021

News

Type A Aortic Dissection Tied to Greater Mortality in Women

Yael L. Maxwell

June 11, 2021

News Daily News

COVID-19: TCTMD’s Daily Dispatch for June Week 2

Todd Neale

June 07, 2021

News Opinion CV Team Dispatch

June 2021 News Roundup

L.A. McKeown

June 01, 2021

News Daily News

COLCORONA: Mixed Results for Colchicine in Nonhospitalized COVID-19

Shelley Wood

May 28, 2021

News Daily News

Dapagliflozin US Cost-effectiveness Data Expose Barriers to HF Care

Shelley Wood

May 27, 2021

News Conference News ACC 2021

Sotagliflozin Beneficial Across a Range of Patients, Including HFpEF

Michael O'Riordan

May 25, 2021

News Conference News EuroPCR 2021

Ultrathin Orsiro Performs Well in All-Comers, Interim CASTLE Data Indicate

Caitlin E. Cox

May 24, 2021

News Daily News

US, European Agencies Looking Into Myocarditis Reports Tied to mRNA COVID-19 Vaccines

Todd Neale

May 24, 2021

News Daily News

COVID-19: TCTMD’s Daily Dispatch for May Week 3

Shelley Wood

May 17, 2021

News Conference News ACC 2021

Dapagliflozin No Help, but No Harm, in Hospitalized COVID-19 Patients

Shelley Wood

May 16, 2021

News Conference News ACC 2021

Evinacumab Lowers Triglycerides in Severe Hypertriglyceridemia

Yael L. Maxwell

May 16, 2021

News Conference News ACC 2021

Sacubitril/Valsartan Lowers Triglycerides in HFpEF: PARAGON-HF

Yael L. Maxwell

May 16, 2021

News Conference News ACC 2021

Low 1-Year Stroke Risk After Commercial Watchman Use

Todd Neale

May 15, 2021

News Conference News ACC 2021

PARADISE-MI: ARNI Doesn’t Surpass ACE Inhibitor After Acute MI

L.A. McKeown

May 15, 2021

Advertisement

OMT Boosts Survival in Revascularized Patients at 10 Years

Less Cancer Among HF Patients Taking Statins, Registry Shows

Sleep Apnea Awareness, Treatment May Improve Some CVD Outcomes: AHA

Statins Not Linked to Dementia or Memory Changes: ASPREE

Stopping Statins Ups CVD and Mortality Risks in Pill-Burdened Seniors

First PCIs Preceded by Many Modifiable Risk Factors: Registry Data

Type A Aortic Dissection Tied to Greater Mortality in Women

COVID-19: TCTMD’s Daily Dispatch for June Week 2

June 2021 News Roundup

COLCORONA: Mixed Results for Colchicine in Nonhospitalized COVID-19

Dapagliflozin US Cost-effectiveness Data Expose Barriers to HF Care

Sotagliflozin Beneficial Across a Range of Patients, Including HFpEF

Ultrathin Orsiro Performs Well in All-Comers, Interim CASTLE Data Indicate

US, European Agencies Looking Into Myocarditis Reports Tied to mRNA COVID-19 Vaccines

COVID-19: TCTMD’s Daily Dispatch for May Week 3

Dapagliflozin No Help, but No Harm, in Hospitalized COVID-19 Patients

Evinacumab Lowers Triglycerides in Severe Hypertriglyceridemia

Sacubitril/Valsartan Lowers Triglycerides in HFpEF: PARAGON-HF

Low 1-Year Stroke Risk After Commercial Watchman Use

PARADISE-MI: ARNI Doesn’t Surpass ACE Inhibitor After Acute MI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content